Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Report

Global and Region Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：206
  • REPORT CODE：GMM889051
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)market, defines the market attractiveness level of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) industry, describes the types of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market and the development prospects and opportunities of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market in Chapter 13.

    By Player:

    • Bristol-Myers Squibb Company

    • Merck & Co, Inc

    • Biogen

    • Eli Lilly and Company

    • GlaxoSmithKline plc

    • AbbVie Inc

    • Amgen Inc

    • Pfizer Inc

    • Novartis AG

    • Johnson & Johnson Services, Inc

    By Type:

    • Aspirin

    • Ibuprofen

    • Naproxen

    • Celecoxib

    • Others

    By End-User:

    • Drug Store

    • Hospital Pharmacies

    • Online

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis and Outlook to 2022

    • 7.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)

    • 7.2 United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)

    • 7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)

    • 7.4 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)

    • 7.5 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)

    • 7.6 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)

    • 7.7 South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption (2017-2022)

    8 Region and Country-wise Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis and Outlook to 2028

    • 8.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)

    • 8.2 United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)

    • 8.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)

    • 8.4 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)

    • 8.5 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)

    • 8.6 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)

    • 8.7 South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast (2022-2028)

    9 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Outlook by Types and Applications to 2022

    • 9.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Aspirin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Ibuprofen Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Naproxen Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Celecoxib Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Drug Store Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Consumption and Growth Rate (2017-2022)

    10 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Outlook by Types and Applications to 2028

    • 10.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Aspirin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Ibuprofen Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Naproxen Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Celecoxib Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Drug Store Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Consumption Forecast and Growth Rate (2022-2028)

    11 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Competitive Analysis

    • 14.1 Bristol-Myers Squibb Company

      • 14.1.1 Bristol-Myers Squibb Company Company Details

      • 14.1.2 Bristol-Myers Squibb Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bristol-Myers Squibb Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • 14.2 Merck & Co, Inc

      • 14.2.1 Merck & Co, Inc Company Details

      • 14.2.2 Merck & Co, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck & Co, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • 14.3 Biogen

      • 14.3.1 Biogen Company Details

      • 14.3.2 Biogen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Biogen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • 14.4 Eli Lilly and Company

      • 14.4.1 Eli Lilly and Company Company Details

      • 14.4.2 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • 14.5 GlaxoSmithKline plc

      • 14.5.1 GlaxoSmithKline plc Company Details

      • 14.5.2 GlaxoSmithKline plc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GlaxoSmithKline plc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • 14.6 AbbVie Inc

      • 14.6.1 AbbVie Inc Company Details

      • 14.6.2 AbbVie Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AbbVie Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • 14.7 Amgen Inc

      • 14.7.1 Amgen Inc Company Details

      • 14.7.2 Amgen Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Amgen Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • 14.8 Pfizer Inc

      • 14.8.1 Pfizer Inc Company Details

      • 14.8.2 Pfizer Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • 14.9 Novartis AG

      • 14.9.1 Novartis AG Company Details

      • 14.9.2 Novartis AG Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Novartis AG Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • 14.10 Johnson & Johnson Services, Inc

      • 14.10.1 Johnson & Johnson Services, Inc Company Details

      • 14.10.2 Johnson & Johnson Services, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Johnson & Johnson Services, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

    • Figure Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Picture

    • Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption by Country (2017-2022)

    • Figure United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)

    • Table Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)

    • Figure Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)

    • Figure India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast by Country (2022-2028)

    • Figure United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aspirin Consumption and Growth Rate (2017-2022)

    • Figure Global Ibuprofen Consumption and Growth Rate (2017-2022)

    • Figure Global Naproxen Consumption and Growth Rate (2017-2022)

    • Figure Global Celecoxib Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Store Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Consumption and Growth Rate (2017-2022)

    • Figure Global Aspirin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ibuprofen Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Naproxen Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Celecoxib Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Store Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Export by Region (Top 5 Countries) (2017-2028)

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • Table Biogen (Foundation Year, Company Profile and etc.)

    • Table Biogen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service

    • Table Johnson & Johnson Services, Inc (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Services, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Services, Inc Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US